Socialiya - Entertainment. Knowledge. Community.
NHS approves new treatment for aggressive cancer that could triple life expectancy

Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour...

HEALTH NEWS April 20, 2026

NHS approves new treatment for aggressive cancer that could triple life expectancy

Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour growth. It works by activating the immune system to...

10 views 0 likes 0 comments
Share:
Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour growth. It works by activating the immune system to...

Author: The Independent

Read Original Article

Related News

Advertisement
APNA POS
Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya